Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): Evidence that mast cells do not belong to the leukaemic clone

Leukemia

Volumn 25, Issue 6, 2011, Pages 1050-1053

  Hussein, K ^a   Horny, H P ^b   Busche G ^a   Gorner M ^c   Gohring G ^a   Kreipe, H ^a   Bock, O ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Institute of Pathology   (Germany)

^c Private Praxis for Haematology and Oncology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB;

ARTICLE; CHRONIC MYELOID LEUKEMIA; DISEASE MARKER; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS;

EID: 79958149333     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.41     Document Type: Article

References (8)

1. Horny HP. Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells. Am J Clin Pathol 2009; 132: 438-447.
2. Agis H, Sotlar K, Valent P, Horny HP. Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis. Leuk Res 2005; 29: 1227-1232. (Pubitemid 41169242)
3. Horny HP, Sotlar K, Stellmacher F, Krokowski M, Agis H, Schwartz LB et al. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006; 59: 298-302. (Pubitemid 43344893)
4. Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O et al. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 2008; 22: 1059-1062. (Pubitemid 351689890)
5. Buesche G, Ganser A, Schlegelberger B, von Neuhoff N, Gadzicki D, Hecker H et al. Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Leukemia 2007; 21: 2420-2427. (Pubitemid 350148883)
6. Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008; 10: 58-66. (Pubitemid 351184836)
7. Michor F. Mathematical models of cancer stem cells. J Clin Oncol 2008; 26: 2854-2861.
8. Abruzzese E, Gozzetti A, Galimberti S, Trawinska MM, Caravita T, Siniscalchi A et al. Characterization of Ph-negative abnormal clones emerging during imatinib therapy. Cancer 2007; 109: 2466-2472. (Pubitemid 46906466)